MPA PK Monitoring Strategy With MMF/FK Based Immunosuppression

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00187941
Recruitment Status : Completed
First Posted : September 16, 2005
Last Update Posted : June 20, 2012
Hoffmann-La Roche
Information provided by (Responsible Party):
University of Florida

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : November 2006
  Actual Study Completion Date : November 2006
Guerra G, Srinivas TR, Schold JD, Eagan AE, Nawrocki, Shaw L, Kaplan B, Womer K, Meier-Kriesche HU. Prospective Blinded Pharmacokinetic Trial to Establish an Individualized MPA Trough Regimen. American Transplant Congress, San Francisco, California